Metabolite concentration as a criterion for antibacterial discovery

Area of Science:

• Pharmaceutical Science
• Systems Biology
• Metabolic Engineering

Background:

• Antibacterial discovery faces significant technical and economic hurdles.
• Advances in omics and systems biology offer new avenues for accelerating drug discovery.

Purpose of the Study:

• To summarize the application of metabolic network analysis in antibacterial discovery.
• To propose metabolite concentration as a criterion for selecting antimicrobial targets.
• To identify novel antibacterial targets and explain experimental observations.

Main Methods:

• Metabolic network analysis was employed to identify essential enzymes.
• Metabolite concentrations were analyzed to determine druggability criteria.
• Solubility of existing antibacterials was compared to substrate concentrations.

Main Results:

• Essential enzymes with low substrate concentrations (< 0.5 mM) are identified as druggable targets.
• Clinically used antibacterials exhibit solubility significantly higher than competed substrate concentrations.
• A new criterion for target selection is proposed, identifying promising antibacterial targets.

Conclusions:

• Metabolite concentration is a viable criterion for selecting effective antimicrobial targets.
• The proposed method aids in identifying novel antibacterial targets and resolving experimental anomalies.
• This approach can revitalize the discovery pipeline for new antibacterial agents.